Exercise and Doxorubicin Modify Markers of Iron Overload and Cardiolipin Deficiency in Cardiac Mitochondria

Doxorubicin (DOX) is a chemotherapeutic agent highly effective at limiting cancer progression. Despite the efficacy of this anticancer drug, the clinical use of DOX is limited due to cardiotoxicity. The cardiac mitochondria are implicated as the primary target of DOX, resulting in inactivation of el...

Descripción completa

Detalles Bibliográficos
Autores principales: Montalvo, Ryan N., Boeno, Franccesco P., Dowllah, Imtiaz M., Moritz, Cesar E. Jacintho, Nguyen, Branden L., Doerr, Vivian, Bomkamp, Matthew P., Smuder, Ashley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177936/
https://www.ncbi.nlm.nih.gov/pubmed/37175395
http://dx.doi.org/10.3390/ijms24097689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177936/
https://www.ncbi.nlm.nih.gov/pubmed/37175395
http://dx.doi.org/10.3390/ijms24097689

Ejemplares similares